Showing results (121-130 of 142) with videos related to
Sort By:
Pageof 15
Emergencias : Revista De La Sociedad Espanola De Medicina De Emergencias|July 29, 2026
Implementation of shock teams and impact on the therapeutic approach and prognosis of cardiogenic shock in SpainMarta Marcos-Mangas, Pablo Jorge-Pérez, Josep Comin-Colet, et al.Journal of the American College of Cardiology|August 30, 2022
Atrial Fibrillation and Dapagliflozin Efficacy in Patients With Preserved or Mildly Reduced Ejection FractionJawad H Butt, Toru Kondo, Pardeep S Jhund, et al.European Heart Journal. Acute Cardiovascular Care|June 9, 2023
Impact of annual volume of cases and intensive cardiac care unit availability on mortality of patients with acute myocardial infarction-related cardiogenic shock treated at revascularization capable centresM Isabel Barrionuevo-Sánchez, Ana Viana-Tejedor, Albert Ariza-Solé, et al.Journal of the American College of Cardiology|November 9, 2024
Effect of Finerenone on the KCCQ in Patients With HFmrEF/HFpEF: A Prespecified Analysis of FINEARTS-HFMingming Yang, Alasdair D Henderson, Atefeh Talebi, et al.Journal of Personalized Medicine|August 25, 2023
Soluble Transferrin Receptor as Iron Deficiency Biomarker: Impact on Exercise Capacity in Heart Failure PatientsMaria Del Mar Ras-Jiménez, Raúl Ramos-Polo, Josep Francesch Manzano, et al.Nature Medicine|December 15, 2022
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trialOrly Vardeny, James C Fang, Akshay S Desai, et al.European Journal of Heart Failure|September 29, 2023
Impact of COVID-19 in patients with heart failure with mildly reduced or preserved ejection fraction enrolled in the DELIVER trialAnkeet S Bhatt, Mikhail N Kosiborod, Brian L Claggett, et al.European Heart Journal|November 4, 2021
Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trialRafael Romaguera, Pablo Salinas, Josep Gomez-Lara, et al.International Journal of Cardiology|October 17, 2019
A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensusDimitrios Farmakis, Piergiuseppe Agostoni, Loant Baholli, et al.Heart (British Cardiac Society)|June 25, 2025
Amphilimus-eluting versus zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: extended follow-up of the SUGAR randomised controlled trialPablo Salinas, Rafael Romaguera, Josep Gómez-Lara, et al.Pageof 15